Imagin Medical Logo
CA45250L2049
A2QEY3
IMEXF

Imagin Medical

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2022, Imagin Medical has already paid €42.76 in dividends. The last payout was in June 2022.

Financials

In the last year, Imagin Medical had revenue of €0 and net profit of -€1.84m
(EUR) 2022
YoY
Revenue 0 -
Gross profit -34.75k 73.64%
Net profit -1.84m 76.48%
EBITDA -2.51m 8.96%

Fundamentals

Metric Value
Market capitalization
€982.03
Number of shares
10.83m
52-week high/low
€0.00997 - €0.0000907
Dividends No
Beta
1.49
P/E ratio
0.00
PEG ratio
0.00
P/B ratio
0.00
P/S ratio
0.00

Company profile

Imagin Medical Inc. operates as a surgical imaging company focusing on bladder cancer. The company is developing the i/Blue Imaging System to meet the BLC needs of urologists. Imagin Medical Inc. was founded in 1986 and is headquartered in Vancouver, Canada.

Name
Imagin Medical
CEO
E. James Hutchens
Headquarters Vancouver, bc
Canada
Website
IPO
23/01/2013
Employees 10

Ticker symbols

Exchange Symbol
Pnk
IMEXF
Frankfurt
DPD3.F
München
DPD3.MU
🍪

Parqet  uses cookies. Learn more